ACCELMED PARTNERS II L.P. purchased 9.7% of their position (390.29K shares) of NEUROPACE INC on the open market
Open‑market purchase worth $585.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/23/2022ACC: 0000899243-22-036949
+390.29K
Net shares
Net buyer
$585.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
390.29K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+327.89K
Price / share
$1.50
Trade value
$491.51K
% of position
8.1%
11/21/2022
4.04M→4.37M
Common Stock
Direct
Shares
+62.40K
Price / share
$1.50
Trade value
$93.53K
% of position
1.4%
11/22/2022
4.37M→4.43M
Total
Net shares
+390.29K
Net value
$585.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2022 | P · Purchase | +327.89K | $1.50 | $491.51K | 8.1% | 4.04M | 4.37M |
| Common Stock Direct | 11/22/2022 | P · Purchase | +62.40K | $1.50 | $93.53K | 1.4% | 4.37M | 4.43M |
| Total | +390.29K | $585.05K | ||||||
Derivative Transactions0
No derivative transactions reported